Eric Winer, MD

Eric Winer, MD, is the Director of Yale Cancer Center, as well as President and Physician-in-Chief of the Smilow Cancer Hospital Yale New Haven Health System. An internationally renowned medical oncologist and expert in breast cancer, he has conducted clinical trials that have changed the face of the disease. His work has impacted almost all aspects of breast cancer.

“First and foremost, I'm a clinician,” Dr. Winer says. “I am fortunate to have been able to spend a great deal of time taking care of patients over the years. Patient care ultimately drives everything that I do professionally, and my patients have been my greatest teachers.”

Dr. Winer has long been an advocate of building teams of scientists and clinicians to accelerate progress in cancer care and research, and appreciates the wealth of experts and resources at Yale involved in this work. “Our mission at Yale is to deliver the best cancer care today and investigate approaches to improve care in the years ahead,” he says.

Dr. Winer is the Alfred Gilman Professor of Medicine and Pharmacology and Deputy Dean of Cancer Research at Yale School of Medicine. His is also Chair of the Board for the American Society of Clinical Oncology (ASCO). For over a decade, he served as chief scientific advisor and chair of the scientific advisory board for Susan G. Komen for the Cure and is now on the scientific advisory board of the Breast Cancer Research Foundation. For the past six years he has co-led the National Cancer Institute breast cancer steering committee.

Dr. Winer has published over 350 research articles, mentored many trainees, and received numerous awards for his breast cancer research. He has served as the principal investigator of a National Institutes of Health-funded SPORE in breast cancer for the last 10 years. “I have seen the transformation of cancer care over the past three decades and look forward to even more remarkable advances over the next decade. I believe Yale will play a prominent role in cancer care and research in the coming years.”